{
    "Trade/Device Name(s)": [
        "Dimension MPO Flex\u00ae reagent cartridge",
        "Dimension MPO Calibrator",
        "Dimension MPO Control"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics",
    "510(k) Number": "K071474",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050029"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NTV",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "November 26, 2008",
    "Summary Letter Received Date": "December 02, 2008",
    "Submission Date": "May 22, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5600"
    ],
    "Regulation Name(s)": [
        "Low-density lipoprotein immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Myeloperoxidase (MPO)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Dimension\u00ae clinical chemistry system with the heterogeneous immunoassay module"
    ],
    "Method(s)/Technology(ies)": [
        "Sandwich enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent cartridge",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension MPO Flex\u00ae reagent cartridge, calibrator, and control for quantitative myeloperoxidase measurement in plasma using the Dimension\u00ae clinical chemistry system.",
    "Indications for Use Summary": "Quantitative measurement of myeloperoxidase in human plasma to aid, with clinical history, ECG, and cardiac biomarkers, in evaluating patients with chest pain at risk for major adverse cardiac events including myocardial infarction, need for revascularization, or death.",
    "fda_folder": "Immunology"
}